The mission of the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute, is to accelerate biopharmaceutical manufacturing innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical...
Dr. Francis Collins is one of the world’s pre-eminent scientists, having directed the extraordinary international Human Genome Project that mapped out humanity’s genes for the first time. He has been elected to the National Academy of Medicine and the National Academy of Sciences and has received the Presidential Medal of Freedom and the National...
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute, announces a grant to help fund the advancement of biopharmaceutical manufacturing technology in the U.S. and globally from the Bill & Melinda Gates Foundation.
NIIMBL will receive up to $1.5M from the foundation to support the...
National Meeting highlights NIIMBL achievements, builds and expands the NIIMBL network, and sets the stage for future collaboration and innovation aimed to advance U.S. biomanufacturing.
The spirit of innovation, collaboration, and community was prevalent as NIIMBL convened its second National Meeting in Washington D.C. on May 16 and 17.
With an...
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a proud member of Manufacturing USA®, is pleased to welcome Genentech, Celgene, Merck, MilliporeSigma and EMD Serono (the U.S. businesses of Merck KGaA, Darmstadt, Germany), among others, to its growing membership base.
These companies join more than 79...
